Stock listing
NASDAQ:SPRY ARS Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of ARS Pharmaceuticals, Inc.
Follow ARS Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SPRY
$3.38 USD -0.28 (-7.7%)
Close on Oct 30, 2026
- Day range
- $3.34 – $3.79 USDOct 30, 2026
- Volume
- 1.75M sharesOct 30, 2026
- Market cap
- $336.1M USDAt the close on Oct 30, 2026 · price × 99.45M shares outstanding
- 52-week range
- $3.34 – $13.15 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $8.08M USDMedian day 1.53M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SPRY · Home | $3.38 USD | -0.28 (-7.7%) | 1,754,250 | $3.62 | $3.79 | $3.34 | $3.66 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SPRY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.38 | -0.28 | -7.7% | $3.62 | $3.79 | $3.34 | 1,754,250 | |
| $3.66 | +0.01 | +0.3% | $3.70 | $3.90 | $3.625 | 2,044,359 | |
| $3.65 | -0.08 | -2.1% | $3.66 | $3.73 | $3.525 | 2,534,720 | |
| $3.73 | -0.19 | -4.8% | $3.92 | $3.945 | $3.64 | 1,643,261 | |
| $3.92 | -0.11 | -2.7% | $4.03 | $4.09 | $3.90 | 1,433,829 | |
| $4.03 | -0.29 | -6.7% | $4.28 | $4.28 | $3.995 | 1,522,100 | |
| $4.32 | +0.14 | +3.3% | $4.13 | $4.355 | $4.13 | 1,786,600 | |
| $4.18 | -0.11 | -2.6% | $4.32 | $4.42 | $4.165 | 1,010,600 | |
| $4.29 | +0.06 | +1.4% | $4.25 | $4.44 | $4.225 | 1,542,700 | |
| $4.23 | +0.21 | +5.2% | $4.07 | $4.32 | $4.00 | 1,509,000 | |
| $4.02 | -0.05 | -1.2% | $4.08 | $4.08 | $3.81 | 2,332,000 | |
| $4.07 | +0.14 | +3.6% | $3.99 | $4.095 | $3.94 | 2,220,100 | |
| $3.93 | -0.12 | -3.0% | $4.01 | $4.095 | $3.885 | 1,728,800 | |
| $4.05 | -0.13 | -3.1% | $4.18 | $4.18 | $3.995 | 1,546,800 | |
| $4.18 | -0.05 | -1.2% | $4.20 | $4.27 | $4.06 | 1,274,300 | |
| $4.23 | -0.33 | -7.2% | $4.53 | $4.555 | $4.20 | 1,258,400 | |
| $4.56 | +0.20 | +4.6% | $4.35 | $4.635 | $4.21 | 1,584,900 | |
| $4.36 | +0.065 | +1.5% | $4.24 | $4.402 | $4.205 | 1,297,800 | |
| $4.295 | +0.005 | +0.1% | $4.31 | $4.31 | $4.08 | 1,219,200 | |
| $4.29 | +0.22 | +5.4% | $4.13 | $4.395 | $4.03 | 1,621,100 | |
| $4.07 | -0.05 | -1.2% | $4.16 | $4.27 | $3.985 | 1,828,500 | |
| $4.12 | -0.19 | -4.4% | $4.35 | $4.395 | $4.11 | 1,971,600 | |
| $4.31 | -0.09 | -2.0% | $4.43 | $4.45 | $4.24 | 1,297,400 | |
| $4.40 | +0.27 | +6.5% | $4.11 | $4.435 | $4.01 | 1,274,700 | |
| $4.13 | +0.05 | +1.2% | $4.06 | $4.19 | $4.00 | 949,800 | |
| $4.08 | -0.07 | -1.7% | $4.18 | $4.18 | $4.02 | 1,035,000 | |
| $4.15 | -0.03 | -0.7% | $4.21 | $4.24 | $4.07 | 1,052,600 | |
| $4.18 | -0.30 | -6.7% | $4.49 | $4.49 | $4.11 | 1,370,300 | |
| $4.48 | +0.13 | +3.0% | $4.40 | $4.57 | $4.36 | 1,268,000 | |
| $4.35 | +0.24 | +5.8% | $4.16 | $4.385 | $4.07 | 1,197,900 | |
| $4.11 | -0.04 | -1.0% | $4.10 | $4.20 | $4.10 | 1,885,800 | |
| $4.15 | -0.015 | -0.4% | $4.26 | $4.30 | $4.12 | 1,870,600 | |
| $4.165 | -0.085 | -2.0% | $4.25 | $4.365 | $4.125 | 1,451,900 | |
| $4.25 | -0.25 | -5.6% | $4.50 | $4.50 | $4.22 | 2,776,000 | |
| $4.50 | -0.26 | -5.5% | $4.80 | $4.90 | $4.455 | 2,165,300 | |
| $4.76 | -0.30 | -5.9% | $5.13 | $5.19 | $4.73 | 2,570,800 | |
| $5.06 | -0.17 | -3.3% | $5.20 | $5.22 | $5.02 | 1,091,300 | |
| $5.23 | -0.16 | -3.0% | $5.35 | $5.38 | $5.215 | 874,500 | |
| $5.39 | -0.23 | -4.1% | $5.515 | $5.535 | $5.305 | 1,086,500 | |
| $5.62 | -0.05 | -0.9% | $5.60 | $5.70 | $5.54 | 849,500 | |
| $5.67 | -0.15 | -2.6% | $5.86 | $5.90 | $5.605 | 1,088,200 | |
| $5.82 | +0.05 | +0.9% | $5.86 | $6.00 | $5.745 | 1,196,700 | |
| $5.77 | -0.23 | -3.8% | $6.08 | $6.08 | $5.74 | 1,358,000 | |
| $6.00 | +0.11 | +1.9% | $5.87 | $6.09 | $5.615 | 1,984,600 | |
| $5.89 | -0.14 | -2.3% | $6.00 | $6.03 | $5.855 | 1,190,300 | |
| $6.03 | 0.00 | 0.0% | $6.03 | $6.12 | $5.89 | 1,190,800 | |
| $6.03 | +0.31 | +5.4% | $5.70 | $6.09 | $5.67 | 1,162,100 | |
| $5.72 | +0.37 | +6.9% | $5.40 | $5.76 | $5.39 | 1,715,834 | |
| $5.35 | -0.155 | -2.8% | $5.40 | $5.46 | $5.20 | 1,936,733 | |
| $5.505 | 0.00 | 0.0% | $5.52 | $5.60 | $5.465 | 1,267,900 | |
| $5.505 | -0.875 | -13.7% | $6.30 | $6.35 | $5.50 | 2,114,100 | |
| $6.38 | +0.08 | +1.3% | $6.42 | $6.58 | $6.35 | 1,212,400 | |
| $6.30 | +0.06 | +1.0% | $6.12 | $6.52 | $6.12 | 1,945,300 | |
| $6.24 | +0.59 | +10.4% | $5.62 | $6.285 | $5.575 | 2,504,800 | |
| $5.65 | -0.45 | -7.4% | $5.10 | $5.84 | $5.00 | 5,046,000 | |
| $6.10 | +0.05 | +0.8% | $6.08 | $6.19 | $5.90 | 1,978,700 | |
| $6.05 | +0.10 | +1.7% | $5.96 | $6.075 | $5.81 | 1,313,900 | |
| $5.95 | +0.04 | +0.7% | $5.98 | $5.98 | $5.80 | 1,351,809 | |
| $5.91 | -0.25 | -4.1% | $6.06 | $6.185 | $5.80 | 1,330,193 | |
| $6.16 | +0.61 | +11.0% | $5.60 | $6.16 | $5.575 | 2,155,800 | |
| $5.55 | +0.19 | +3.5% | $5.38 | $5.60 | $5.38 | 1,264,500 | |
| $5.36 | +0.04 | +0.8% | $5.32 | $5.46 | $5.22 | 2,542,300 | |
| $5.32 | -0.14 | -2.6% | $5.50 | $5.50 | $5.23 | 1,931,400 | |
| $5.46 | +0.33 | +6.4% | $5.08 | $5.485 | $4.91 | 2,143,500 | |
| $5.13 | -0.50 | -8.9% | $5.55 | $5.605 | $5.11 | 2,083,400 | |
| $5.63 | -0.20 | -3.4% | $5.80 | $5.853 | $5.48 | 1,626,700 |
- Ticker
- NASDAQ:SPRY
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
ARS Pharma to Report Third Quarter 2026 Financial Results
Latest earnings call · Aug 13, 2026
ARS Pharmaceuticals (NASDAQ:SPRY) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 15, 2026
Investor Presentation (May 2026)
Investor deck · 22 slides
Calls
Upcoming
ARS Pharmaceuticals (NASDAQ:SPRY) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Register
Replays
ARS Pharmaceuticals (NASDAQ:SPRY) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 4:30 PM ET
Watch TranscriptARS Pharmaceuticals (NASDAQ:SPRY) Q1 2026 Earnings Call
Fri, May 15, 2026 · 8:30 AM ET
Watch TranscriptARS Pharmaceuticals (NASDAQ:SPRY) Q4 2025 Earnings Call
Mon, Mar 09, 2026 · 8:30 AM ET
Watch Transcript
Latest news
ARS Pharma to Report Third Quarter 2026 Financial Results
Oct 28, 2026
Closed $3.66 (+0.3%) on Oct 29, 2026
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
Oct 5, 2026
Closed $4.29 (+5.4%) on Oct 5, 2026
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $5.65 (-7.4%) on Aug 14, 2026
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
Aug 3, 2026
Closed $5.46 (+6.4%) on Aug 3, 2026
ARS Pharmaceuticals Announces CEO Succession
Jul 7, 2026
Closed $8.10 (-1.1%) on Jul 8, 2026
ARS Pharmaceuticals Provides Commercial and Financial Updates
Jun 24, 2026
Closed $10.54 (+2.5%) on Jun 24, 2026
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
Jun 4, 2026
Closed $9.07 (+3.7%) on Jun 4, 2026
ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update
May 15, 2026
Closed $7.43 (-6.5%) on May 15, 2026
ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
May 13, 2026
Closed $8.01 (-7.2%) on May 13, 2026
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
May 7, 2026
Closed $9.00 (-3.0%) on May 7, 2026
Decks
Investor Presentation (May 2026)
Investor deck · 22 slides · May 15, 2026
Q4 2025 Earnings Presentation
Earnings · 22 slides · Mar 9, 2026
Investor Presentation (November 2025)
Investor deck · 19 slides · Nov 10, 2025
Q3 2025 Earnings Presentation
Earnings · 10 slides · Nov 10, 2025
ARS Pharmaceuticals, Inc. on 6ix
- News releases
- 27 in the last 12 months · 93 in all · newest Oct 28, 2026 · oldest 2023
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 13, 2026
- Decks
- 20 decks · latest May 15, 2026
Where ARS Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SPRY · Home listing · This page | NASDAQ | United States | USD |
| BOATS:SPRY | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about ARS Pharmaceuticals, Inc.